logo

For the Inventor, By the Inventor

Mississauga, Canada

Raafat Emil Fahim

This inventor holds 8 USPTO granted patents. Top assignees: Connaught Laboratories Limited, Washington University, Other. Active years: 1995-2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Raafat Emil Fahim. Retrieved from https://idiyas.com/inventor/raafat-emil-fahim

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 8

% Patents Active = 100.0

Average Co-Inventor Count = 6.2

ph-index = 4

Forward Citations = 71(Granted Patents)


Location History:

  • Mississauge, CA (1999)
  • Mississauga, CA (1995 - 2002)

Company Filing History:

goldMedal7 out of 145 
 
Connaught Laboratories Limited
 patents
silverMedal1 out of 1,384 
 
Washington University
 patents
bronzeMedal1 out of 834,601 
Other
 patents
where one patent can have more than one assignee

Years Active: 1995-2002

Loading Chart...
8 patents (USPTO):Explore Patents
1. 6444211 - Purification of a pertussis outer membrane protein (2002-09-03),
2. 6165774 - Parainfluenza virus glycoproteins and vaccines (2000-12-26),
3. 5985288 - Outer membrane protein P1 and peptides of Haemophilus influenzae type B (1999-11-16),
4. 5916562 - Membrane proteins and peptides of haemophilus influenzae type B (1999-06-29),
5. 5877298 - Acellular pertussis vaccines and methods of preparing thereof (1999-03-02),
6. 5681570 - Immunogenic conjugate molecules (1997-10-28),
7. 5667787 - Purification of a pertussis outer membrane protein (1997-09-16),
8. 5444159 - Purification of a pertussis outer membrane protein (1995-08-22),

Title: Inventor Profile: Raafat Emil Fahim

Introduction

Raafat Emil Fahim is an esteemed inventor based in Mississauga, Canada, known for his significant contributions to biotechnology. With a total of 8 patents to his name, he has made notable advancements in the field, particularly in the purification of proteins and vaccine development.

Latest Patents

One of his latest patents focuses on the purification of a pertussis outer membrane protein, Pertactin. This innovation involves recovering Pertactin in a stable biologically pure form from fermentation broth, which is processed to selectively remove pertussis toxin (PT) and filamentous haemagglutinin (FHA). The purification process utilizes ammonium sulphate precipitation, hydroxyapatite, and ion-exchange chromatography, followed by final ultrafiltration to ensure high purity levels. This method holds promise for enhancing the safety and efficacy of vaccines against whooping cough.

Career Highlights

Throughout his career, Raafat has demonstrated expertise in protein purification and vaccine research. His work at various esteemed organizations, including Connaught Laboratories Limited, showcases his commitment to advancing healthcare through innovative solutions.

Collaborations

Raafat has collaborated with notable professionals in his field, including Michel Henri Klein and Gail E. Jackson. These partnerships have enabled him to enhance his research initiatives and contribute to significant advancements in biotechnology.

Conclusion

In conclusion, Raafat Emil Fahim’s dedication to innovation in protein purification and vaccine development marks him as a prominent figure in the biotechnology sector. His extensive patent portfolio reflects his contributions to improving public health and advancing scientific knowledge.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…